Treatment of Hypertriglyceridemia
The treatment of hypertriglyceridemia should begin with comprehensive lifestyle modifications, followed by pharmacological therapy based on triglyceride levels, with fibrates being the first-line medication for severe hypertriglyceridemia (≥500 mg/dL). 1, 2
Classification of Triglyceride Levels
- Normal: <150 mg/dL
- Borderline high: 150-199 mg/dL
- High: 200-499 mg/dL
- Very high: ≥500 mg/dL
- Severe: 1,000-1,999 mg/dL
- Very severe: ≥2,000 mg/dL 2
Treatment Algorithm Based on Triglyceride Levels
For All Patients with Hypertriglyceridemia:
- Lifestyle Modifications
For Triglycerides 150-499 mg/dL:
- Continue lifestyle modifications
- Pharmacological Therapy:
For Triglycerides 500-999 mg/dL:
More aggressive lifestyle modifications:
Pharmacological Therapy:
For Triglycerides ≥1,000 mg/dL:
Most aggressive lifestyle modifications:
Pharmacological Therapy:
Fenofibrate Dosing Guidelines
- Initial dose for severe hypertriglyceridemia: 54-160 mg per day 3
- Dosage should be individualized according to patient response 3
- Adjust dose following repeat lipid determinations at 4-8 week intervals 3
- Maximum dose: 160 mg once daily 3
- For patients with impaired renal function: start at 54 mg per day 3
Monitoring and Follow-up
- Check lipid panels 4-8 weeks after initiating therapy 2
- Primary goal: reduce triglycerides to <150 mg/dL 2
- For severe hypertriglyceridemia: immediate goal is to reduce triglycerides to <500 mg/dL to prevent pancreatitis 2
- Monitor liver and renal function with pharmacological therapy, especially when using fibrates 2
Important Considerations and Cautions
- Combination of statins with gemfibrozil increases risk of myositis; fenofibrate is preferred when combining with statins 2
- Evaluate for secondary causes of hypertriglyceridemia:
- Markedly elevated triglycerides (>2,000 mg/dL) significantly increase risk of pancreatitis 3
- Fenofibrate should be given with meals to optimize bioavailability 3
- Consider withdrawing therapy if inadequate response after two months of maximum dose 3
By following this structured approach to managing hypertriglyceridemia, clinicians can effectively reduce triglyceride levels, minimize the risk of pancreatitis in severe cases, and potentially reduce cardiovascular risk in patients with elevated triglycerides.